Transcend Medical, Inc.™ is focused on the research and development of novel devices for the treatment of glaucoma, the leading cause of adult irreversible blindness. Over two million people in the U.S. alone are afflicted with the disease today and the numbers are expected to grow to three million by the year 2020. The Transcend Medical approach is focused on replacing the current therapies for the treatment of glaucoma with a less invasive procedure and minimal complications.
|
LATEST UPDATES
|
||
|
08/31/2009 Transcend Medical Expands Leadership Team Appointing Chief Medical Officer and Vice President of Clinical Affairs 06/22/2009 Transcend Medical Raises 35 Million Series B Round Towards Development of Novel Glaucoma treatment 09/09/2008 Transcend Medical Announces New President and CEO Appointment of Chairman of the Board 04/02/2007 ForSight Labs, LLC Announces New CEO Appointment and the Series A Funding of a Second Company |
||